Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
National Journal of Andrology ; (12): 216-220, 2018.
Article in Chinese | WPRIM | ID: wpr-689774

ABSTRACT

<p><b>Objective</b>To investigate the relationship between seminal plasma zinc alpha-2 glycoprotein (ZAG) and semen quality in obese males.</p><p><b>METHODS</b>This study included 130 obese male patients with idiopathic infertility Based on the concentration of seminal plasma ZAG, we divided the patients into three tertile groups: tertile 1 (T1, 73.45-97.15 μg/ml, n = 43), T2 (97.16-115.46 μg/ml, n = 44), and T3 (115.47-220.11 μg/ml, n = 43). We measured the concentrations of seminal plasma zinc (SPZ) and ZAG of the patients by ELISA, obtained the semen parameters, and analyzed the correlation of semen quality with the levels of SPZ and ZAG and the influence of obesity on SPZ, ZAG and semen quality.</p><p><b>RESULTS</b>The mean level of seminal plasma ZAG in the 130 obese male patients was (111.29 ± 26.50) μg/ml. There were statistically significant differences in sperm concentration and total sperm count among the three tertile groups (P < 0.05). The level of seminal plasma ZAG was correlated negatively with the body mass index (BMI), waist circumference (WC), sperm concentration and sperm count (P < 0.01), that of SPZ positively with BMI and WC (P < 0.05) but negatively with semen volume and the percentage of progressively motile sperm (P < 0.05). The level of serum ZAG, however, exhibited no correlation with SPZ, seminal plasma ZAG or semen quality. Obesity was found to be associated with significantly decreased concentration of seminal plasma ZAG and percentage of progressively motile sperm but remarkably increased level of SPZ (P < 0.05).</p><p><b>CONCLUSIONS</b>Obesity may induce the metabolic disorder of SPZ and ZAG, change the microenvironment of seminal plasma, and consequently affect semen quality.</p>


Subject(s)
Humans , Male , Body Mass Index , Infertility, Male , Metabolism , Obesity , Metabolism , Semen , Chemistry , Semen Analysis , Seminal Plasma Proteins , Sperm Count , Sperm Motility , Spermatozoa , Metabolism , Waist Circumference
2.
National Journal of Andrology ; (12): 997-1001, 2017.
Article in Chinese | WPRIM | ID: wpr-812843

ABSTRACT

Objective@#To study the changes of the serum zinc alpha 2 glycoprotein (ZAG) level in men and its relationship with blood lipid male reproductive hormones.@*METHODS@#We enrolled 297 men aged 25- 65 years in this study, 152 with hyperlipemia (HL) and the other 145 with normal blood lipid (normal control). We divided them into four age groups (25-35 yr, 36-45 yr, 46-55 yr, and 56-65 yr) and three tertile groups (Q1, Q2, and Q3) according to the tertiles of the serum ZAG level, and examined their blood lipid, blood glucose, serum ZAG, and reproductive hormones.@*RESULTS@#The serum ZAG level was decreased gradually with the increase of age in both the HL patients and normal controls, significantly in the 36-45 and 56-65 yr age groups (P <0.05), and markedly lower in the HL than in the control men in the 25-35 and 36-45 yr groups (P <0.05). The levels of follicle-stimulating hormone (FSH) and total testosterone (TT) changed significantly with the ZAG level. The level of serum ZAG was correlated negatively with age (r = -0.58, P<0.05), waist circumference (r = -0.21, P <0.05), body mass index (BMI) (r = -0.22, P <0.05), fasting blood glucose (r = -0.16, P <0.05) , and triglyceride (TG) (r = -0.27, P <0.05) but positively with TT (r = 0.36, P <0.05). Age, BMI and TG were independent factors influencing the serum ZAG level.@*CONCLUSIONS@#The serum ZAG level is decreased with the increase of age and associated with lipid metabolism, abdominal obesity, and reproductive hormone levels in males.


Subject(s)
Adult , Aged , Humans , Male , Middle Aged , Age Factors , Blood Glucose , Body Mass Index , Follicle Stimulating Hormone , Gonadal Steroid Hormones , Blood , Lipids , Blood , Obesity, Abdominal , Reproduction , Seminal Plasma Proteins , Blood , Triglycerides , Blood
3.
Acta bioquím. clín. latinoam ; 48(3): 291-300, set. 2014. ilus, graf, tab
Article in Spanish | LILACS | ID: lil-734238

ABSTRACT

En pacientes diabéticos tipo 2 normoalbuminúricos se observa la presencia de Microproteínas Urinarias (MU) en el rango 68-25 kDa. El objetivo del trabajo fue identificar en distintos estadios de la nefropatía diabética si dicho rango corresponde a un marcador de daño tubular. Se estudiaron 119 orinas espontáneas de pacientes diabéticos tipo 2; se les midió la relación albúmina/creatinina urinaria y la creatinina sérica. Se dividieron en 5 grupos: 71 normoalbuminúricos, 28 microalbuminúricos, 12 macroalbuminúricos, 2 urémicos en pre-diálisis y 6 en hemodiálisis. Las MU se detectaron en geles de poliacrilamida en 2 dimensiones para uso clínico y se analizaron con el programa Image J 1.30v. La identificación de las MU se realizó por “immunoblotting” o por espectrometría de masa MALDI-TOF-TOF. El 66% de los normoalbuminúricos presentaron las siguientes MU: orosomucoide, fragmento de 35 kDa de la cadena pesada H4 del inter alfa I inhibidor de tripsina y Beta Trace, las cuales no reflejaron daño tubular debido a que la concentración de las mismas no se incrementó en los pacientes en hemodiálisis, en comparación con los normoalbuminúricos. Dichas proteínas están vinculadas al endotelio vascular y podrían constituir un marcador urinario vascular-tubular renal de utilidad clínica en patologías sistémicas con riesgo cardiovascular y funcionalidad renal conservada.


Urinary excretion of microproteins (MU) was detected in normoalbuminuric type 2 diabetic patients, in the range of 68-25 kDa using SDS-PAGE with silver staining. The purpose of this study was to identify MU in diabetic patients in different grades of diabetic nephropathy, in order to clarify the diagnostic relevance as a marker of renal tubular damage. In the spontaneous urine of 119 type 2 diabetic patients, urinary albumin, urinary creatinine and serum were determined. Five groups were formed: 71 normoalbuminuric, 28 microalbuminuric, 12 macroalbuminuric, 2 in pre-dialysis and 6 in hemodialysis. The MU were separated by two-dimensional polyacrylamid gel electrophoresis for clinical use (2D UC) and were identified by immunoblotting or MALDI-TOF-TOF mass spectrometry and analyzed using Image J version 1.30v. Of the normoalbuminurics patients studied, 66% excreted the following MU: orosomucoid, 35 kDa fragment of inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4) and Beta Trace; but their concentrations did not reflect tubular damage because they exhibited a progressive downregulation. These proteins are involved in vascular endothelium, and they could be a marker of renal tubular-microvascular disease that would be useful in systemic diseases with cardiovascular risk and with preserved renal function.


Em pacientes diabéticos tipo 2 “normoalbuminúricos” se observa a presença de microproteínas urinárias (MU) em um intervalo compreendido entre 68 e 25 kDa. O objetivo do trabalho é identificar em distintos estágios da nefropatia diabética se tal intervalo corresponde a um marcador de dano tubular. Foram estudadas 119 amostras de urina espontânea de pacientes diabéticos tipo 2; foi medida a reação albumina/creatinina urinária e a creatinina sérica. Dividiram-se em 5 grupos: 71 normoalbuminúricos, 28 microalbuminúricos, 12 macroalbuminúricos, 2 urêmicos pré-dialise e 6 em hemodiálise. Foram detectadas as MU em géis de poliacrilamida em duas dimensões para o uso clínico e analisadas com o programa Image J versão 1.30v. A identificação das MU foi realizada por “immunoblotting” ou por espectrometria de massa MALDI-TOF-TOF. 66% de normoalbuminúricos apresentaram as seguintes MU: orosomucoide, Fragmento de 35 kDa da cadeia pesada H4 do interalfa inibidor da tripsina e Beta Trace, as quais não mostraram dano tubular devido a que a concentração das mesmas não está aumentada nos pacientes em hemodiálise, em comparação com os normoalbuminúricos. Estas proteínas estão envolvidas com o endotélio vascular e poderiam constituir um marcador urinário vascular-tubular renal de utilidade clínica em patologias sistêmicas com risco cardiovascular e funcionalidade renal conservada.


Subject(s)
Humans , Diabetes Mellitus, Type 2/urine , Diabetic Nephropathies/urine , Albuminuria , Creatinine/urine , Diabetes Mellitus, Type 2 , Urine
SELECTION OF CITATIONS
SEARCH DETAIL